（文章来源：证券日报） 证券日报网讯 8月22日晚间，通策医疗发布公告称，公司全资子公司通策口腔投资收购上海存济口腔门 诊部有限公司（以下简称"标的公司"）99%股权，全资子公司杭州通盛医疗投资管理有限公司收购标的 公司1%股权，交易总金额为4600万元，交易资金来源为自有资金。本次交易构成关联交易。 ...

证券日报网讯 8月22日晚间，通策医疗发布公告称，公司第十届监事会第九次会议审议通过了《关于取 消监事会免去监事的议案》等多项议案。 （文章来源：证券日报） ...

（文章来源：证券日报） 证券日报网讯 8月22日晚间，通策医疗发布公告称，公司第十届董事会第十次会议审议通过了《关于确 认审计委员会成员及推选召集人的议案》等多项议案。 ...

（文章来源：证券日报） 证券日报网讯 8月22日晚间，通策医疗发布公告称，2025年半年度公司实现营业收入1，448，440， 275.71元，同比增长2.68%；归属于上市公司股东的净利润为321，157，553.42元，同比增长3.67%。 ...

Group 1: Company Announcements - Changjiang Electric Power's controlling shareholder, China Three Gorges Group, plans to increase its stake in the company by 4 billion to 8 billion yuan within the next 12 months through secondary market transactions [1] - Huakin Technology is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy and overseas business development [2] - Tailin Microelectronics is planning to acquire all or part of the equity of Shanghai Panqi Microelectronics through a combination of share issuance and cash payment, with trading suspended for up to 10 trading days [3] - Jingwang Electronics intends to invest 5 billion yuan in expanding its Zhuhai Jinwan base to enhance its competitiveness in high-end products related to AI and other technologies [5] - Jiangsu Guotai plans to use up to 12 billion yuan of idle funds for entrusted wealth management in low-risk financial products [6] Group 2: Financial Performance - Ping An Bank reported a 3.9% year-on-year decline in net profit for the first half of 2025, with a proposed cash dividend of 2.36 yuan per 10 shares [1][9] - Several companies reported significant increases in net profit, including Zhezhang Securities with a 46.49% increase and Keg Precision Machinery with a 144% increase [7] - True Love Home reported a net profit of 197 million yuan, a year-on-year increase of 484.48% [8] - Companies like Kunlun Wanwei and Vanke A reported substantial losses, with net losses of 856 million yuan and 11.947 billion yuan respectively [9]

Group 1 - The core viewpoint of the article highlights Tongce Medical's strategic acquisition to expand its market presence in Shanghai and its positive financial performance in the first half of the year [1] Group 2 - As of August 22, 2025, Tongce Medical's stock price was 46.74 yuan, up 0.95% from the previous trading day, with a trading volume of 115,058 lots and a transaction amount of 533 million yuan [1] - Tongce Medical specializes in oral medical services, including dental implants, orthodontics, and pediatric dentistry, operating through a regional headquarters and branch model to create a comprehensive medical service network [1] - The company announced plans to acquire 100% equity of Shanghai Cunjie Dental Clinic for 46 million yuan through its wholly-owned subsidiary, which will help further expand its business layout in Shanghai [1] - In the first half of the year, Tongce Medical reported operating revenue of 1.45 billion yuan, a year-on-year increase of 2.7%, and a net profit attributable to shareholders of 321 million yuan, up 3.7% year-on-year [1]

Core Viewpoint - Tongce Medical has strategically entered the Shanghai market by acquiring a 99% stake in Shanghai Cunjie Dental Clinic for a total transaction amount of 46 million yuan, which is expected to enhance its brand presence and optimize its business structure [1] Group 1 - The acquisition involves Tongce Medical's wholly-owned subsidiary Zhejiang Tongce Oral Hospital Investment Management Group Co., Ltd. acquiring 99% of Shanghai Cunjie Dental [1] - The total transaction amount for the acquisition is 46 million yuan [1] - The move is anticipated to improve the company's revenue sources and profitability, positively impacting its future financial status and operational results [1] Group 2 - The acquisition is seen as a strategic entry into a key market, which will enhance the brand's influence in the high-end market [1] - The company aims to further optimize its regional business layout and product service structure through this acquisition [1]

智通财经APP讯，通策医疗(600763.SH)发布2025年半年度报告，报告期内，公司实现营业收入14.48亿 元，同比增长2.68%。实现归属于上市公司股东的净利润3.21亿元，同比增长3.67%。实现归属于上市公 司股东的扣除非经常性损益的净利润3.17亿元，同比增长3.85%。基本每股收益0.72元。 ...

Company Overview - Shanghai Congji Dental Clinic Co., Ltd. was established on July 5, 2023, in the Pudong New Area of Shanghai, with a registered capital of RMB 1 million [1] - The company is invested by Shanghai Tongce Dental Hospital Co., Ltd. and operates under the business scope of medical services [1] Financial Reporting Basis - The financial statements are prepared based on the going concern assumption and in accordance with the accounting standards issued by the Ministry of Finance [2] - The accounting records are maintained on an accrual basis, with historical cost as the measurement basis, except for certain financial instruments [2] Accounting Policies - The accounting period is divided into annual and interim periods, with the fiscal year running from January 1 to December 31 [2] - The company uses Renminbi as its functional currency for accounting purposes [2] Financial Assets and Liabilities - Financial assets are classified based on the business model for managing them and their cash flow characteristics, including those measured at amortized cost and at fair value [3][4] - Financial liabilities are classified into those measured at fair value with changes recognized in profit or loss and other financial liabilities [5][6] Impairment and Credit Losses - The company recognizes impairment losses for financial assets measured at amortized cost and those measured at fair value with changes recognized in other comprehensive income [10][11] - Expected credit losses are measured based on the credit risk of financial assets since initial recognition, with different methods applied depending on whether credit risk has significantly increased [12][13] Government Grants - Government grants are classified into those related to assets and those related to income, with specific accounting treatments for each type [18][19] - Grants related to assets are recognized as deferred income and amortized over the useful life of the related assets [21] Taxation - The corporate income tax rate is set at 20% on taxable income [25] - The company benefits from reduced tax rates for small and micro enterprises as per the relevant government policies [25]

证券简称：通策医疗 证券代码：600763 编号：临 2025-021 公司将取消监事会，免去监事张晓露先生、赵敏女士，原监事会的职权由董事会 审计委员会行使，同时废止《公司监事会议事规则》，并对《公司章程》中相关条款 做出相应修订。 在公司股东会审议通过取消监事会前，公司第十届监事会仍将严格按照《公司法》 《上市公司治理准则》等法律法规和规章制度的要求，勤勉尽责履行监督职能，维护 公司和全体股东利益。 表决结果：3 票同意；0 票弃权；0 票反对。 该议案需提请公司股东会审议。 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《通 策医疗股份有限公司关于修订 <公司章程> 及其他制度的公告》。 通策医疗股份有限公司 第十届监事会第九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带责任。 通策医疗股份有限公司（以下简称"本公司"、"公司"）第十届监事会第九次会 议于 2025 年 8 月 22 日在公司会议室召开，监事会会议通知及相关文件以书面通知、 电话确认的方式通知全体监事。本次 ...